David Low
Stock Analyst at UBS
(3.65)
# 2,174
Out of 5,133 analysts
322
Total ratings
51.7%
Success rate
5.3%
Average return
Main Sectors:
Stocks Rated by David Low
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $26.00 | $13.58 | +91.46% | 10 | Nov 4, 2026 | |
| ASX: COH Cochlear Limited | Reiterated: Hold | $135.00 | $151.37 | -10.81% | 25 | Nov 3, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Buy | $225.00 | $202.92 | +10.88% | 34 | Nov 3, 2026 | |
| ASX: RMD ResMed Inc. | Reiterated: Buy | n/a | $34.96 | - | 27 | Nov 2, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Reiterated: Hold | $55.60 | $55.03 | +1.04% | 22 | Oct 29, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Reiterated: Hold | $21.20 | $19.89 | +6.59% | 35 | Oct 29, 2026 | |
| ASX: ANN Ansell Limited | Reiterated: Hold | $38.70 | $46.31 | -16.43% | 18 | Oct 4, 2026 | |
| ASX: REG Regis Healthcare Limited | Reiterated: Hold | $6.75 → $5.95 | $5.13 | +15.98% | 16 | Sep 2, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Reiterated: Buy | $3.25 → $3.40 | $1.67 | n/a | 12 | Aug 27, 2025 | |
| ASX: NAN Nanosonics Limited | Reiterated: Sell | $4.00 → $3.90 | $2.83 | n/a | 20 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.30 | $0.89 | n/a | 1 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47.17 → $44.72 | $21.40 | n/a | 3 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.62 | $0.58 | n/a | 26 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $282.00 → $300.00 | $202.57 | n/a | 5 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $290 → $310 | $239.53 | n/a | 43 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32.00 → $35.00 | $48.48 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.95 → $0.78 | $0.27 | n/a | 4 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.48 | n/a | 7 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $34.41 | n/a | 1 | Dec 4, 2019 |
Telix Pharmaceuticals Limited
Nov 4, 2026
Reiterated: Buy
Price Target: $26.00
Current: $13.58
Upside: +91.46%
Cochlear Limited
Nov 3, 2026
Reiterated: Hold
Price Target: $135.00
Current: $151.37
Upside: -10.81%
CSL Limited
Nov 3, 2026
Reiterated: Buy
Price Target: $225.00
Current: $202.92
Upside: +10.88%
ResMed Inc.
Nov 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $34.96
Upside: -
Ramsay Health Care Limited
Oct 29, 2026
Reiterated: Hold
Price Target: $55.60
Current: $55.03
Upside: +1.04%
Sonic Healthcare Limited
Oct 29, 2026
Reiterated: Hold
Price Target: $21.20
Current: $19.89
Upside: +6.59%
Ansell Limited
Oct 4, 2026
Reiterated: Hold
Price Target: $38.70
Current: $46.31
Upside: -16.43%
Regis Healthcare Limited
Sep 2, 2026
Reiterated: Hold
Price Target: $6.75 → $5.95
Current: $5.13
Upside: +15.98%
Integral Diagnostics Limited
Aug 27, 2025
Reiterated: Buy
Price Target: $3.25 → $3.40
Current: $1.67
Upside: n/a
Nanosonics Limited
Aug 27, 2025
Reiterated: Sell
Price Target: $4.00 → $3.90
Current: $2.83
Upside: n/a
Aug 27, 2025
Reiterated: Hold
Price Target: $1.30
Current: $0.89
Upside: n/a
Aug 27, 2025
Reiterated: Hold
Price Target: $47.17 → $44.72
Current: $21.40
Upside: n/a
Aug 25, 2025
Reiterated: Sell
Price Target: $0.62
Current: $0.58
Upside: n/a
Aug 14, 2025
Reiterated: Hold
Price Target: $282.00 → $300.00
Current: $202.57
Upside: n/a
Aug 1, 2025
Reiterated: Buy
Price Target: $290 → $310
Current: $239.53
Upside: n/a
Jun 3, 2025
Reiterated: Hold
Price Target: $32.00 → $35.00
Current: $48.48
Upside: n/a
Mar 2, 2025
Reiterated: Buy
Price Target: $0.95 → $0.78
Current: $0.27
Upside: n/a
Aug 23, 2021
Reiterated: Hold
Price Target: n/a
Current: $13.48
Upside: n/a
Dec 4, 2019
Downgraded: Hold
Price Target: n/a
Current: $34.41
Upside: n/a